PTEN and neoplasm: In contrast to the conventional scoring approach based on estimation of the percentage of aberrant nuclei9, 12, the new score represents the ratio of PTEN to CEP10 of a given tumour region without the requirement for recognizing distinct nuclei13, 14, therefore diminishing the signal loss effect caused by cutting artifacts15.